MedReleaf (LEAF) PT Raised to C$30.00

MedReleaf (TSE:LEAF) had its price target upped by Canaccord Genuity from C$21.50 to C$30.00 in a research note issued on Wednesday. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity’s price target would suggest a potential upside of 41.91% from the stock’s current price.

Several other analysts also recently commented on the company. Cowen increased their price objective on MedReleaf from C$20.00 to C$36.00 in a research note on Monday, January 8th. Eight Capital increased their price objective on MedReleaf from C$13.00 to C$20.00 and gave the stock a “buy” rating in a research note on Wednesday, November 15th.

Shares of MedReleaf (TSE LEAF) traded up C$1.39 during trading on Wednesday, hitting C$21.14. The stock had a trading volume of 649,906 shares, compared to its average volume of 1,013,119. The stock has a market capitalization of $1,970.00 and a P/E ratio of 1,053.50. MedReleaf has a 12-month low of C$6.81 and a 12-month high of C$31.25.

In related news, insider Stephen Arbib sold 50,600 shares of the stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of C$18.00, for a total transaction of C$910,800.00. Also, insider Olam Ltd. Tikun sold 28,600 shares of the stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of C$25.00, for a total value of C$715,000.00. Over the last three months, insiders sold 1,145,100 shares of company stock valued at $25,037,466.

WARNING: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/02/14/medreleaf-leaf-pt-raised-to-c30-00.html.

MedReleaf Company Profile

MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.

Receive News & Ratings for MedReleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedReleaf and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply